Journal for ImmunoTherapy of Cancer (Feb 2022)
Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Feb 2022)